Tuesday, April 30, 2024
Home BUSINESS NAFDAC prohibits sale of 'Dex Luxury' soap in Nigeria

NAFDAC prohibits sale of ‘Dex Luxury’ soap in Nigeria

-

NAFDAC, while banning the soap, said it can cause harm to the health of the unborn child, and lead to skin sensitization

By Kehinde Okeowo

The National Agency for Food and Drug Administration Control (NAFDAC), has prohibited the sale of Dex Luxury bar soap in Nigeria.

NAFDAC informed the public about the ban on Thursday via its X page, where it said the product was prohibited because it contained Butyphenyl Methylpropional, BMHCA.

- Advertisement -

It went on to explain that European Union, EU, had already banned the product due to the risk of harming the reproductive system of users.

It then educated the citizens that using the soap can cause harm to the health of an unborn child, and cause skin sensitization.

ALSO READ: Air Peace in dire strait as big players cut London route price to kick it out of business

The agency tweeted: “Public Alert No. 012/2024.Ban on the sale of Dex Luxury Bar Soap due to Butyphenyl Methylpropional (BMHCA) content.

“NAFDAC is notifying the public of the ban on the sale of Dex Luxury Bar Soap (No 6 mystic flower) by the European Union (EU).

- Advertisement -

“The product does not comply with the Cosmetic Products Regulation as it is said to contain Butyphenyl Methylpropional (BMHCA) which is prohibited in cosmetic products due to its risk of harming the reproductive system, causing harm to the health of the unborn child, and may cause skin sensitization.

“As a result, a ban on the marketing of the product has been placed by some regulatory and public authorities in the EU.

“Product Name: Dex Luxury Bar Soap (No 6 Mystic Flower), Product Brand: DEX, Country of Manufacture: Turkey, Model: 11.11.22, Barcode: 8694965531, Category: Cosmetics.

“Although this product is not on the NAFDAC database, importers, distributors, retailers, and consumers are advised to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and use of the above-mentioned product.

“Healthcare professionals and consumers are advised to report any suspicion of adverse reactions or substandard and falsified regulated products to the nearest NAFDAC office.”

Must Read